A single-center retrospective study of Sacubitril/Valsartan in Cardiac Reverse Remodeling in Ischemic vs. Nonischemic Cardiomyopathy.
Latest Information Update: 22 May 2020
At a glance
- Drugs Sacubitril/valsartan (Primary)
- Indications Cardiomyopathies; Heart failure
- Focus Therapeutic Use
Most Recent Events
- 22 May 2020 New trial record
- 25 Apr 2020 Results presented at the 40th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation